Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Clinical Insights

Clinical Insights
An Update on Microwave Ablation With David J. Breen, MRCP, FRCR
04/27/2016
IO360: Tell us about your facility and your practice.Breen: I am an interventional radiologist with Spire Southampton University Hospital in the United Kingdom. There is a large interventional oncology practice within the UK, and in terms of...
IO360: Tell us about your facility and your practice.Breen: I am an interventional radiologist with Spire Southampton University Hospital in the United Kingdom. There is a large interventional oncology practice within the UK, and in terms of...
IO360: Tell us about your...
04/27/2016
IO Learning
Clinical Insights
Irreversible Electroporation as a Treatment for Hilar Renal Cell Carcinoma Adjacent to the Colon and Inferior Vena Cava
04/01/2016
Abstract: A 54-year-old female presented with an incidentally discovered 2.9 cm renal cell carcinoma centered near the hilum of the right kidney and in close proximity to the colon and inferior vena cava. Given its anatomical position,...
Abstract: A 54-year-old female presented with an incidentally discovered 2.9 cm renal cell carcinoma centered near the hilum of the right kidney and in close proximity to the colon and inferior vena cava. Given its anatomical position,...
Abstract: A 54-year-old female...
04/01/2016
IO Learning
Clinical Insights
The Center for Interventional Oncology at the National Institutes of Health: An Interview With Bradford Wood, MD
04/01/2016
Bradford Wood, MD, is director of the Center for Interventional Oncology, chief of interventional radiology, and a senior researcher with the National Institutes of Health (NIH). The Center for Interventional Oncology is a collaboration among...
Bradford Wood, MD, is director of the Center for Interventional Oncology, chief of interventional radiology, and a senior researcher with the National Institutes of Health (NIH). The Center for Interventional Oncology is a collaboration among...
Bradford Wood, MD, is director...
04/01/2016
IO Learning
Clinical Insights
Transradial Approach for Interventional Oncology: An Interview With Darren Klass, MD
03/28/2016
Darren Klass, MD, PhD, MRCS, FRCR, FRCPC, is an interventional radiologist at Vancouver Coastal Health, in Vancouver, British Columbia, Canada. He is head of the MRI division and specializes in interventional oncology, aortic intervention,...
Darren Klass, MD, PhD, MRCS, FRCR, FRCPC, is an interventional radiologist at Vancouver Coastal Health, in Vancouver, British Columbia, Canada. He is head of the MRI division and specializes in interventional oncology, aortic intervention,...
Darren Klass, MD, PhD, MRCS,...
03/28/2016
IO Learning
Clinical Insights
Bradford Wood, MD, Describes the First Use of Radiopaque Embolic Beads
03/22/2016
Bradford Wood, MD, director of the Center for Interventional Oncology at the National Institutes of Health, recently participated in the first interventional oncology cases performed using the LC Bead Lumi (BTG), the first radiopaque embolic...
Bradford Wood, MD, director of the Center for Interventional Oncology at the National Institutes of Health, recently participated in the first interventional oncology cases performed using the LC Bead Lumi (BTG), the first radiopaque embolic...
Bradford Wood, MD, director of...
03/22/2016
IO Learning
Clinical Insights
Miami Cancer Institute: State-of-the-Art Technology and Innovative Patient Care
03/14/2016
In late 2016, Baptist Health South Florida will open the new Miami Cancer Institute, a destination cancer center that will offer groundbreaking clinical trials, the latest technology, and compassionate patient care. When the...
In late 2016, Baptist Health South Florida will open the new Miami Cancer Institute, a destination cancer center that will offer groundbreaking clinical trials, the latest technology, and compassionate patient care. When the...
In late 2016, Baptist Health...
03/14/2016
IO Learning
Clinical Insights
Robotics in Interventional Oncology: Articles From the Official Show Daily for Synergy 2015
03/08/2016
Intravascular robotics represent the latest advancement in the evolution of endovascular interventions. One of the primary objectives of this novel technology is the facilitation of guidewire and catheter navigation, especially in the setting...
Intravascular robotics represent the latest advancement in the evolution of endovascular interventions. One of the primary objectives of this novel technology is the facilitation of guidewire and catheter navigation, especially in the setting...
Intravascular robotics represent...
03/08/2016
IO Learning
Clinical Insights
Current Status of Interventional Oncology for Breast Cancer Liver Metastases: Articles From the Official Show Daily for Synergy 2015
03/08/2016
Breast cancer is the most common cancer in women and the second most frequent cause of cancer deaths in women after lung cancer in developed nations.1 Half of patients with metastatic breast cancer (MBC) will be diagnosed with liver...
Breast cancer is the most common cancer in women and the second most frequent cause of cancer deaths in women after lung cancer in developed nations.1 Half of patients with metastatic breast cancer (MBC) will be diagnosed with liver...
Breast cancer is the most common...
03/08/2016
IO Learning
Clinical Insights
Selective Internal Radiation Therapy With Yttrium-90 Resin Microspheres in Metastatic Colorectal Carcinoma: The SIRFLOX Study: Articles From the Official Show Daily for Synergy 2015
02/15/2016
Selective internal radiation therapy (SIRT) with yttrium-90 (Y90) resin microspheres has demonstrated support of level I evidence in phase 3 clinical trials in first-line colorectal disease (in an older era of chemotherapeutic intervention,...
Selective internal radiation therapy (SIRT) with yttrium-90 (Y90) resin microspheres has demonstrated support of level I evidence in phase 3 clinical trials in first-line colorectal disease (in an older era of chemotherapeutic intervention,...
Selective internal radiation...
02/15/2016
IO Learning
Clinical Insights
Prostatic Artery Embolization for Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms: Articles From the Official Show Daily for Synergy 2015
02/15/2016
The standard management of benign prostatic obstruction (BPO) is based on the overall health of the patient, on the severity of the lower urinary tract symptoms (LUTS), and on quality-of-life considerations. Voiding difficulties attributable...
The standard management of benign prostatic obstruction (BPO) is based on the overall health of the patient, on the severity of the lower urinary tract symptoms (LUTS), and on quality-of-life considerations. Voiding difficulties attributable...
The standard management of...
02/15/2016
IO Learning

Advertisement

Subscribe

IO Learning Newsletter

News

News
Novel Endovascular Robotic Surgical System Reaches Midpoint of Pivotal Clinical Trial
09/20/2024
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY® Endovascular Robotic Surgical System has enrolled and completed follow-up for 50% of patients.
The ACCESS-PVI trial of LIBERTY®...
09/20/2024
IO Learning
News
Histotripsy Demonstrates Technical Success, Safety for Primary and Metastatic Liver Tumors
09/04/2024
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the parallel #HOPE4LIVER trials, the novel ablation technique of histotripsy met coprimary end points for technical success and safety among patients with primary and metastatic liver tumors.
According to results from the...
09/04/2024
IO Learning
News
Sorafenib Plus Transarterial Chemoembolization Improves Survival Outcomes, Response Among Patients With Recurrent Hepatocellular Carcinoma
07/29/2024
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial, the addition of sorafenib to TACE improved survival outcomes and response among patients with recurrent intermediate-stage hepatocellular carcinoma after R0 initial hepatectomy and microvascular invasion.
According to a phase 3 trial,...
07/29/2024
Oncology
News
Thermal Ablation Over Surgical Resection for Patients With Smaller Colorectal Liver Metastases
07/18/2024
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3 COLLISION trial, thermal ablation for smaller colorectal liver metastases reduced morbidity and mortality without compromising survival outcomes compared to surgical resection.
According to the phase 3...
07/18/2024
IO Learning
News
Manageable Safety Across Treatment Periods for Durvalumab, Bevacizumab, and TACE Regimen Among Patients With Unresectable Hepatocellular Carcinoma
07/17/2024
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc, exploratory analysis of safety by treatment period in the EMERALD-1 study, durvalumab plus bevacizumab plus transarterial chemoembolization had a manageable safety profile across both treatment periods among patients...
According to a post-hoc,...
07/17/2024
IO Learning
News
Transit Scientific Announces First Worldwide Case Performed with Innovative Embolic-Delivery Microcatheter
07/09/2024
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press Release Park City, Utah USA, July 9, 2024 – Transit Scientific, a Utah-based medical device company specializing in innovative solutions for vascular procedures, proudly announces the successful debut of XO...
Transit Scientific Press...
07/09/2024
Vascular Disease Management
Imaging Systems
University Hospitals Cleveland, Siemens Healthineers in New Alliance to Improve Oncology, Cardiovascular and Neurovascular Care for Patients
05/08/2024

Siemens Healthineers and University Hospitals Cleveland News

Siemens Healthineers and University H...
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance cardiovascular services of the UH Harrington Heart & Vascular Institute with the world’s first clinically available photon-counting CT scanner and the new dual-source CT scanner.
The new alliance will enhance...
05/08/2024
Cath Lab Digest
News
Histotripsy Treatment for Primary and Metastatic Liver Tumors
04/25/2024
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual Meeting, first results from the #HOPE4LIVER trial evaluating histotripsy for primary and metastatic liver tumors were reported.
At the 2023 CIRSE Annual...
04/25/2024
IO Learning
News
First-of-Its-Kind Surgical Foam Technology Improves Operating Room Workflow
04/24/2024

Syntervention Press Release

Syntervention Press Release
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina, USA, April 24, 2024 — Syntervention, Inc., a medical device company focused on meeting critical needs in the healthcare space, announces the impact of using its SWICKER® Radiopaque Surgical Foam Sponge in open...
Rocky Mount, North Carolina,...
04/24/2024
EP Lab Digest
News
Fluidx Medical Reveals New Embolic Platform for Internal Bleeding, Tumor Treatment, and Other Uses
11/30/2023
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx Medical today released information about their new ULTRA™ embolic platform designed to make therapeutic embolization procedures safer, better, and faster.   Embolization is a minimally invasive...
Salt Lake City (UT) – Fluidx...
11/30/2023
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement